Bionano Genomics (BNGO) Other Non-Current Assets (2020 - 2026)

Bionano Genomics' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $2.7 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets changed N/A year-over-year to $2.7 million; the TTM figure through Mar 2026 stood at $2.7 million (changed N/A YoY), while the FY2025 annual figure was $2.7 million, down 2.18% from the prior year.
• Other Non-Current Assets came in at $2.7 million for Q1 2026 at Bionano Genomics, down from $2.7 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $11.4 million in Q2 2024 to a low of $400000.0 in Q4 2022.
• A 5-year average of $2.0 million and a median of $400000.0 in 2022 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets soared 2752.0% in 2024 and slumped 81.69% in 2025, its largest moves.
• Bionano Genomics' Other Non-Current Assets stood at $400000.0 in 2022, then changed by 0.0% to $400000.0 in 2023, then soared by 588.5% to $2.8 million in 2024, then slipped by 2.18% to $2.7 million in 2025, then decreased by 0.59% to $2.7 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $2.7 million, $2.7 million, and $1.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison